1 Pharma Stock to Buy for Under $1 This December Pharma company Rigel’s (RIGL) REZLIDHIA recently achieved the U.S. Food and Drug Administration’s approval for treating relapsed or refractory acute myeloid leukemia, helping the stock to soar. RIGL shares have… Previous Article Can Bilibili be the Chinese Version of YouTube? Next Article Here’s What to Expect for the S&P 500 in 2023
